Clinplus (301257.SZ) Stalls Amid 18% Drop: What Investors Need to KnowExplore Clinplus (301257.SZ) market insights: flat trading, 18% decline, 200‑day support, and growth prospects in gene‑editing therapeutics.CLINPLUSChina AI generated Samantha Roth 22/10/2026, 15:54 3 minutes to read
Clinplus Shares Hold Steady as Obesity Drug Shows Promising Weight‑Loss ResultsClinplus stock unchanged at CNY 34.17; 20% fall vs‑month, but new obesity trial shows 68‑week weight loss and upcoming market launch.CLINPLUSChina AI generated Elliot Mercer 21/10/2026, 10:20 2 minutes to read